Access cutting-edge sarcoma treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access sarcoma specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sarcoma treatment provided free
This research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to determine how effective this combination of drugs is at treating Ewing Sarcoma (EWS) and Desmoplastic Small Round Cell Tumor (DSRCT), as well as multiple other kinds of sarcomas. The names of the study drugs and biological agents involved in this study are: * PEEL-224 (a type of Topoisomerase 1 inhibitor) * Vincristine (A type of vinca alkalo
Sponsor: David S Shulman, MD
Check if you qualify for this sarcoma clinical trial in Boston, MA
If you're searching for sarcoma treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.